State Street’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.58M Buy
82,142
+983
+1% +$30.8K ﹤0.01% 3219
2025
Q1
$2.41M Buy
81,159
+3,894
+5% +$116K ﹤0.01% 3173
2024
Q4
$2.28M Buy
77,265
+594
+0.8% +$17.5K ﹤0.01% 3279
2024
Q3
$2.39M Buy
76,671
+29,897
+64% +$931K ﹤0.01% 3266
2024
Q2
$1.59M Buy
46,774
+1,328
+3% +$45K ﹤0.01% 3389
2024
Q1
$2.95M Buy
45,446
+1,920
+4% +$125K ﹤0.01% 3139
2023
Q4
$2.97M Buy
43,526
+1,160
+3% +$79.3K ﹤0.01% 3172
2023
Q3
$2.2M Buy
42,366
+1,512
+4% +$78.5K ﹤0.01% 3288
2023
Q2
$2.45M Buy
40,854
+1,688
+4% +$101K ﹤0.01% 3316
2023
Q1
$1.94M Buy
39,166
+2,936
+8% +$145K ﹤0.01% 3352
2022
Q4
$2.07M Buy
36,230
+27,279
+305% +$1.56M ﹤0.01% 3365
2022
Q3
$420K Sell
8,951
-2,883
-24% -$135K ﹤0.01% 3842
2022
Q2
$442K Buy
+11,834
New +$442K ﹤0.01% 3881
2022
Q1
Sell
-6,316
Closed -$216K 4922
2021
Q4
$216K Buy
6,316
+116
+2% +$3.97K ﹤0.01% 4315
2021
Q3
$230K Buy
+6,200
New +$230K ﹤0.01% 4304